These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24920786)

  • 1. Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis.
    Zhang ZJ; Bi Y; Li S; Zhang Q; Zhao G; Guo Y; Song Q
    Am J Epidemiol; 2014 Jul; 180(1):11-4. PubMed ID: 24920786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin use and lung cancer risk in patients with diabetes.
    Sakoda LC; Ferrara A; Achacoso NS; Peng T; Ehrlich SF; Quesenberry CP; Habel LA
    Cancer Prev Res (Phila); 2015 Feb; 8(2):174-9. PubMed ID: 25644512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re.: "Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis".
    Schmedt N; Azoulay L; Hense S
    Am J Epidemiol; 2014 Dec; 180(12):1216-7. PubMed ID: 25395024
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: "reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis".
    Hense HW; Geier AS
    Am J Epidemiol; 2014 Dec; 180(11):1130-1. PubMed ID: 25414205
    [No Abstract]   [Full Text] [Related]  

  • 5. Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis.
    Yao L; Liu M; Huang Y; Wu K; Huang X; Zhao Y; He W; Zhang R
    Dis Markers; 2019; 2019():6230162. PubMed ID: 30881522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
    Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner.
    Tsai MJ; Yang CJ; Kung YT; Sheu CC; Shen YT; Chang PY; Huang MS; Chiu HC
    Lung Cancer; 2014 Nov; 86(2):137-43. PubMed ID: 25267165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
    Nie SP; Chen H; Zhuang MQ; Lu M
    Asian Pac J Cancer Prev; 2014; 15(16):6863-9. PubMed ID: 25169538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.
    Zhang ZJ; Zheng ZJ; Shi R; Su Q; Jiang Q; Kip KE
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2347-53. PubMed ID: 22523334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.
    Noto H; Goto A; Tsujimoto T; Noda M
    PLoS One; 2012; 7(3):e33411. PubMed ID: 22448244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
    Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
    Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.
    Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL
    Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.
    Decensi A; Puntoni M; Goodwin P; Cazzaniga M; Gennari A; Bonanni B; Gandini S
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1451-61. PubMed ID: 20947488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin for lung cancer prevention and improved survival: a novel approach.
    Roos JF; Qudsi M; Samara A; Rahim MM; Al-Bayedh SA; Ahmed H
    Eur J Cancer Prev; 2019 Jul; 28(4):311-315. PubMed ID: 29481337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.
    Zhang ZJ; Zheng ZJ; Kan H; Song Y; Cui W; Zhao G; Kip KE
    Diabetes Care; 2011 Oct; 34(10):2323-8. PubMed ID: 21949223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis.
    Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X
    J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.
    Zhang H; Gao C; Fang L; Zhao HC; Yao SK
    Scand J Gastroenterol; 2013 Jan; 48(1):78-87. PubMed ID: 23137049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of metformin on mortality following cancer among patients with diabetes.
    Lega IC; Shah PS; Margel D; Beyene J; Rochon PA; Lipscombe LL
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1974-84. PubMed ID: 25030683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
    Kowall B; Stang A; Rathmann W; Kostev K
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.